english.prescrire.org > Spotlight > 100 most recent > In the February issue of Prescrire International: Liposomal forms of drugs

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

In the February issue of Prescrire International: Liposomal forms of drugs

FREE DOWNLOAD Healthcare professionals must take great care at every stage of the medication-use process when dealing with drugs that are available in liposomal and non-liposomal forms.
Full text available for free download.

Abstract

  • Some drugs, such as injectable amphotericin B, doxorubicin and irinotecan, are marketed in liposomal and non­liposomal forms, but these forms are not interchangeable.
     
  • The European Union has taken action to prevent errors in this situation, by adding “liposomal” or “pegylated liposomal” to the brand name.
     
  • As an added precaution, it is useful to refer to these drugs on prescriptions and in other healthcare documents by their INN + the form (liposomal or non­liposomal) + the brand name.

©Prescrire 1 February 2021

Source: "Liposomal forms of drugs: now specified in the brand name, but no improvement to the INN" Prescrire International 2021; 30 (223): 48. Free.

Enjoy full access to Prescrire International, and support independent information

Share
Share on  Facebook Share on  Twitter


Read more:

All the subjects in
Prescrire's Spotlight
Free >